Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 391

1.

Duloxetine in the treatment of depression: a double-blind placebo-controlled comparison with paroxetine.

Goldstein DJ, Lu Y, Detke MJ, Wiltse C, Mallinckrodt C, Demitrack MA.

J Clin Psychopharmacol. 2004 Aug;24(4):389-99.

PMID:
15232330
[PubMed - indexed for MEDLINE]
2.

Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial.

Detke MJ, Wiltse CG, Mallinckrodt CH, McNamara RK, Demitrack MA, Bitter I.

Eur Neuropsychopharmacol. 2004 Dec;14(6):457-70.

PMID:
15589385
[PubMed - indexed for MEDLINE]
3.

Duloxetine 60 mg once-daily in the treatment of painful physical symptoms in patients with major depressive disorder.

Brannan SK, Mallinckrodt CH, Brown EB, Wohlreich MM, Watkin JG, Schatzberg AF.

J Psychiatr Res. 2005 Jan;39(1):43-53.

PMID:
15504423
[PubMed - indexed for MEDLINE]
4.

Duloxetine, 60 mg once daily, for major depressive disorder: a randomized double-blind placebo-controlled trial.

Detke MJ, Lu Y, Goldstein DJ, Hayes JR, Demitrack MA.

J Clin Psychiatry. 2002 Apr;63(4):308-15.

PMID:
12000204
[PubMed - indexed for MEDLINE]
5.

Effectiveness of low doses of paroxetine controlled release in the treatment of major depressive disorder.

Trivedi MH, Pigotti TA, Perera P, Dillingham KE, Carfagno ML, Pitts CD.

J Clin Psychiatry. 2004 Oct;65(10):1356-64.

PMID:
15491239
[PubMed - indexed for MEDLINE]
6.

Duloxetine in the treatment of major depressive disorder: a double-blind clinical trial.

Goldstein DJ, Mallinckrodt C, Lu Y, Demitrack MA.

J Clin Psychiatry. 2002 Mar;63(3):225-31.

PMID:
11926722
[PubMed - indexed for MEDLINE]
7.

Once-daily duloxetine 60 mg in the treatment of major depressive disorder: multicenter, double-blind, randomized, paroxetine-controlled, non-inferiority trial in China, Korea, Taiwan and Brazil.

Lee P, Shu L, Xu X, Wang CY, Lee MS, Liu CY, Hong JP, Ruschel S, Raskin J, Colman SA, Harrison GA.

Psychiatry Clin Neurosci. 2007 Jun;61(3):295-307.

PMID:
17472599
[PubMed - indexed for MEDLINE]
8.

Duloxetine for the treatment of major depressive disorder: a closer look at efficacy and safety data across the approved dose range.

Mallinckrodt CH, Prakash A, Andorn AC, Watkin JG, Wohlreich MM.

J Psychiatr Res. 2006 Jun;40(4):337-48. Epub 2005 Nov 4.

PMID:
16271726
[PubMed - indexed for MEDLINE]
9.

Duloxetine 60 mg once daily dosing versus placebo in the acute treatment of major depression.

Detke MJ, Lu Y, Goldstein DJ, McNamara RK, Demitrack MA.

J Psychiatr Res. 2002 Nov-Dec;36(6):383-90.

PMID:
12393307
[PubMed - indexed for MEDLINE]
10.

Duloxetine in the treatment of major depressive disorder: a placebo- and paroxetine-controlled trial.

Perahia DG, Wang F, Mallinckrodt CH, Walker DJ, Detke MJ.

Eur Psychiatry. 2006 Sep;21(6):367-78. Epub 2006 May 11.

PMID:
16697153
[PubMed - indexed for MEDLINE]
11.

Desvenlafaxine 50 and 100 mg/d in the treatment of major depressive disorder: an 8-week, phase III, multicenter, randomized, double-blind, placebo-controlled, parallel-group trial and a post hoc pooled analysis of three studies.

Tourian KA, Padmanabhan SK, Groark J, Brisard C, Farrington D.

Clin Ther. 2009 Jun;31 Pt 1:1405-23. doi: 10.1016/j.clinthera.2009.07.006.

PMID:
19698901
[PubMed - indexed for MEDLINE]
12.

The effect of duloxetine on painful physical symptoms in depressed patients: do improvements in these symptoms result in higher remission rates?

Fava M, Mallinckrodt CH, Detke MJ, Watkin JG, Wohlreich MM.

J Clin Psychiatry. 2004 Apr;65(4):521-30.

PMID:
15119915
[PubMed - indexed for MEDLINE]
13.

A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder.

Arnold LM, Lu Y, Crofford LJ, Wohlreich M, Detke MJ, Iyengar S, Goldstein DJ.

Arthritis Rheum. 2004 Sep;50(9):2974-84.

PMID:
15457467
[PubMed - indexed for MEDLINE]
Free Article
14.

Duloxetine in treatment of anxiety symptoms associated with depression.

Dunner DL, Goldstein DJ, Mallinckrodt C, Lu Y, Detke MJ.

Depress Anxiety. 2003;18(2):53-61.

PMID:
12964171
[PubMed - indexed for MEDLINE]
15.

Efficacy and safety of duloxetine 60 mg once daily in the treatment of pain in patients with major depressive disorder and at least moderate pain of unknown etiology: a randomized controlled trial.

Brecht S, Courtecuisse C, Debieuvre C, Croenlein J, Desaiah D, Raskin J, Petit C, Demyttenaere K.

J Clin Psychiatry. 2007 Nov;68(11):1707-16.

PMID:
18052564
[PubMed - indexed for MEDLINE]
16.

Duloxetine for the treatment of major depressive disorder: safety and tolerability associated with dose escalation.

Wohlreich MM, Mallinckrodt CH, Prakash A, Watkin JG, Carter WP.

Depress Anxiety. 2007;24(1):41-52.

PMID:
16845641
[PubMed - indexed for MEDLINE]
17.

Duloxetine efficacy for major depressive disorder in male vs. female patients: data from 7 randomized, double-blind, placebo-controlled trials.

Kornstein SG, Wohlreich MM, Mallinckrodt CH, Watkin JG, Stewart DE.

J Clin Psychiatry. 2006 May;67(5):761-70.

PMID:
16841626
[PubMed - indexed for MEDLINE]
18.

Efficacy of controlled-release paroxetine in the treatment of late-life depression.

Rapaport MH, Schneider LS, Dunner DL, Davies JT, Pitts CD.

J Clin Psychiatry. 2003 Sep;64(9):1065-74.

PMID:
14628982
[PubMed - indexed for MEDLINE]
19.

A comparison of initial duloxetine dosing strategies in patients with major depressive disorder.

Whitmyer VG, Dunner DL, Kornstein SG, Meyers AL, Mallinckrodt CH, Wohlreich MM, Gonzales JS, Greist JH.

J Clin Psychiatry. 2007 Dec;68(12):1921-30.

PMID:
18162024
[PubMed - indexed for MEDLINE]
20.

Duloxetine in the treatment of Major Depressive Disorder: a comparison of efficacy in patients with and without melancholic features.

Mallinckrodt CH, Watkin JG, Liu C, Wohlreich MM, Raskin J.

BMC Psychiatry. 2005 Jan 4;5:1.

PMID:
15631624
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk